Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor.
Saved in:
| Title: | Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor. |
|---|---|
| Authors: | Montagna, Daniela R.1 (AUTHOR) daniela.r.montagna@gmail.com, Duarte, Alejandra2 (AUTHOR), Chiarella, Paula1 (AUTHOR), Rearte, Bárbara3 (AUTHOR), Bustuoabad, Oscar D.1 (AUTHOR), Vermeulen, Mónica4 (AUTHOR), Ruggiero, Raúl A.1 (AUTHOR) |
| Source: | BMC Cancer. 8/3/2022, Vol. 22 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
